Nanobiotix Newswire

Comprehensive Real-Time News Feed for Nanobiotix.

Results 1 - 15 of 15 in Nanobiotix

  1. Rectal Cancer - Pipeline Review, H1 2014 - New Report AvailableRead the original story

    Friday Apr 11 | SBWire

    ... Chemical Corporation, Eisai Co., Ltd., Merck KGaA, Peregrine Pharmaceuticals, Inc., Synta Pharmaceuticals Corp., Nanobiotix, Isofol Medical AB, AbbVie Inc. About Fast Market Research Fast Market Research is a leading distributor of market research ...

    Comment?

  2. New Market Study Published: Brain Metastasis - Pipeline Review, H1 2014Read the original story

    Thursday Apr 10 | SBWire

    ... Roche Ltd., Sanofi, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Cell Therapeutics, Inc., Nanobiotix, Spectrum Pharmaceuticals, Inc., Philogen S.p.A., Nerviano Medical Sciences S.r.l., AngioChem Inc., Diffusion Pharmaceuticals LLC, ...

    Comment?

  3. "Colon Cancer - Pipeline Review, H1 2014" Now Available at Fast Market ResearchRead the original story

    Thursday Apr 10 | SBWire

    ... plc, Microbio Co., Ltd., Transgene Biotek Limited, Rexahn Pharmaceuticals, Inc., MabVax Therapeutics, Inc., Nanobiotix, Aurigene Discovery Technologies Limited, Supratek Pharma Inc., Actinium Pharmaceuticals, Inc., Quantum Pharmaceuticals, Ironwood ...

    Comment?

  4. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Thursday Apr 3 | Business Wire

    )--Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext : NANO - ISIN: FR0011341205), sociA tA franA aise pionniA re en nanomA decine dA veloppant NanoXray, une approche thA rapeutique... )--OPKO Health, Inc. (NYSE:OPK) today ...

    Comment?

  5. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Tuesday Apr 1 | Business Wire

    ... has announced the addition of the "Fixed Resistor Trends" report to their offering. ... Nanobiotix slectionne pour prsenter les donnes de l'tude de NBTXR3 lors de la 50me confrence de l'American Society of Clinical Oncology (ASCO) )--Regulatory ...

    Comment?

  6. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Tuesday Apr 1 | Business Wire

    ... has announced the addition of the "Fixed Resistor Trends" report to their offering. ... Nanobiotix slectionne pour prsenter les donnes de l'tude de NBTXR3 lors de la 50me confrence de l'American Society of Clinical Oncology (ASCO) )--Regulatory ...

    Comment?

  7. French nanomedicine firm seeks cash, U.S. partner against cancerRead the original story

    Feb 14, 2014 | Reuters

    French nanomedicine firm Nanobiotix is searching for a partner in the United States and plans to raise fresh capital this year to bring to market its cancer-killing technology, its chief executive said on Friday.

    Comment?

  8. Small cap movers: AIM firms see some of the New Year 'froth coming...Read the original story w/Photo

    Feb 14, 2014 | This Is Money

    ... Muscular Dystrophy and an antibiotic to combat C.difficile infections. Outside AIM, the story of the sector was Nanobiotix , which is Euronext-listed. It more than tripled in value as it said its first device, which applies nano-technology to ...

    Comment?

  9. Nanobiotix sees Clinical Advance in Soft Tissue Sarcoma Pilot Trial with Lead Product, NBTXR3Read the original story

    Feb 11, 2014 | Drugs.com

    Paris, France, 10 February, 2014 - NANOBIOTIX , a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today its development plan for the CE marking of NBTXR3, the first product from the NanoXray pipeline.

    Comment?

  10. Nanobiotix: Sees Clinical Advance In Soft Tissue Sarcoma Pilot Trial...Read the original story

    Feb 11, 2014 | BioSpace

    NANOBIOTIX , a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today its development plan for the CE marking of NBTXR3, the first product from the NanoXray pipeline.

    Comment?

  11. Nanobiotix :Strengthens Its Nanoxray Pipeline With The Launch Of...Read the original story

    Dec 6, 2013 | BioSpace

    NANOBIOTIX , a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today, in accordance with its plans, the selection of its new product, NBTX-TOPO, in view of its preclinical development.

    Comment?

  12. NANOBIOTIX :strengthens its NanoXray pipeline with the launch of...Read the original story

    Dec 5, 2013 | Hispanic Business

    Third product from the NanoXray platform, this unique product combines two important functions: a more efficient eradication of remaining cancer cells following the surgical removal of a tumor and a more accurate localization of a tumor.

    Comment?

  13. Matignon Technologies - Medical Equipment - Investment Profile - New Market ReportRead the original story

    Dec 3, 2013 | PR-inside.com

    ... Financed Companies Alveolus, Inc. (Inactive) Key Information Major Products and Services Headquarters Competitors Nanobiotix Key Information Major Products and Services Key Employees Headquarters Competitors Gentis Inc. Key Information Major ...

    Comment?

  14. Prasad receives honorary doctorate from Sweden's Royal Institute of TechnologyRead the original story w/Photo

    Nov 18, 2013 | University at Buffalo

    ... in science and technology. His research has contributed to the creation of several spin-off companies, including Nanobiotix, a French firm that recently completed a successful IPO. Under Prasad's leadership, ILPB has created novel, ultrasensitive ...

    Comment?

  15. New Market Report Now Available: Head and Neck Cancer - Pipeline Review, H2 2013Read the original story

    Oct 16, 2013 | SBWire

    ... Inc., Oncolytics Biotech Inc., Curis, Inc., Transgene SA, Panacea Biotec Limited, Natco Pharma Limited, Nanobiotix, Wilex AG, Multimmune GmbH, Hawthorn Pharmaceuticals, Inc., PDS Biotechnology Corporation, Oncolys BioPharma Inc., Etubics ...

    Comment?